Agios Pharmaceuticals Inc. buy Bank of America Co.
Start price
22.07.25
/
50%
€33.80
Target price
22.07.26
€43.63
Performance (%)
-33.73%
Price
13.02.26
€23.60
Summary
This prediction is currently active. Massive losses of -33.73% have been the result for the BUY prediction by Bank_of_America_Co_. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 3.540% | 3.540% |
| iShares Core DAX® | 1.927% | -2.112% |
| iShares Nasdaq 100 | -0.184% | -5.899% |
| iShares Nikkei 225® | 7.076% | 6.457% |
| iShares S&P 500 | -0.201% | -3.667% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Bank of America Corporation from $52.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€28.80
24.12.26
24.12.26
-0.84%
13.02.26
13.02.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.00
20.11.25
20.11.25
€27.77
20.11.26
20.11.26
18.00%
13.02.26
13.02.26